207 related articles for article (PubMed ID: 35157300)
1. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
[TBL] [Abstract][Full Text] [Related]
2. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs.
Lee HJ; Kim HJ; Lee SJ
Genome Res; 2020 May; 30(5):768-775. PubMed ID: 32327447
[TBL] [Abstract][Full Text] [Related]
5. Optimized CRISPR/Cas9 system for gene knockout in chicken DF1 cells.
Zou K; Wang F; Zhang Z; Zhou Y; Li P; Wang D; Zhu M; Jia C; Wei Z
Poult Sci; 2023 Oct; 102(10):102970. PubMed ID: 37562129
[TBL] [Abstract][Full Text] [Related]
6. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization.
Fierro J; DiPasquale J; Perez J; Chin B; Chokpapone Y; Tran AM; Holden A; Factoriza C; Sivagnanakumar N; Aguilar R; Mazal S; Lopez M; Dou H
Sci Rep; 2022 Feb; 12(1):2417. PubMed ID: 35165339
[TBL] [Abstract][Full Text] [Related]
7. Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing.
Zhou L; Li R; Zhang R; Peng R; Chen K; Gao P; Zhang J; Zhang R; Li J
J Clin Lab Anal; 2020 Jul; 34(7):e23256. PubMed ID: 32118319
[TBL] [Abstract][Full Text] [Related]
8. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
9. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA.
Zhang Q; Fu Y; Thakur C; Bi Z; Wadgaonkar P; Qiu Y; Xu L; Rice M; Zhang W; Almutairy B; Chen F
Biochem Biophys Res Commun; 2020 Jul; 528(1):54-61. PubMed ID: 32460957
[TBL] [Abstract][Full Text] [Related]
11. Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple
Lombardi L; Oliveira-Pacheco J; Butler G
mSphere; 2019 Mar; 4(2):. PubMed ID: 30867327
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout in
Zhou Y; Hui W; Zhang H; Zou L; Zhang P
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):320-327. PubMed ID: 31068316
[TBL] [Abstract][Full Text] [Related]
13. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
14. Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts.
Petersen BL; Möller SR; Mravec J; Jørgensen B; Christensen M; Liu Y; Wandall HH; Bennett EP; Yang Z
BMC Biotechnol; 2019 Jun; 19(1):36. PubMed ID: 31208390
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
16. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
17. [ADRB2 Gene Knockout in Human Primary T Cells by Multiple sgRNAs Construced using CRISPR/Cas9 Technology].
Sun Y; Liu D; Shi M; Zheng JN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1682-1690. PubMed ID: 31607332
[TBL] [Abstract][Full Text] [Related]
18. A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures.
Hoellerbauer P; Kufeld M; Arora S; Wu HJ; Feldman HM; Paddison PJ
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1269. PubMed ID: 32721120
[TBL] [Abstract][Full Text] [Related]
19. Efficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli.
Nødvig CS; Hoof JB; Kogle ME; Jarczynska ZD; Lehmbeck J; Klitgaard DK; Mortensen UH
Fungal Genet Biol; 2018 Jun; 115():78-89. PubMed ID: 29325827
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 as a tool to dissect cancer mutations.
Sayed S; Paszkowski-Rogacz M; Schmitt LT; Buchholz F
Methods; 2019 Jul; 164-165():36-48. PubMed ID: 31078796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
